The dodecapeptide angiotensin-(1-12) generates Ang II directly from chymase in the human heart, providing an alternative noncanonical renin-independent pathway for adverse cardiac remodeling.
Although it is well-known that excess renin angiotensin system (RAS) activity contributes to the pathophysiology of cardiac and vascular disease, tissue-based expression of RAS genes has given rise to the possibility that intracellularly produced angiotensin II (Ang II) may be a critical contributor to disease processes. An extended form of angiotensin I (Ang I), the dodecapeptide angiotensin-(1-12) Ang-(1-12), that generates Ang II directly from chymase, particularly in the human heart, reinforces the possibility that an alternative noncanonical renin independent pathway for Ang II formation may be important in explaining the mechanisms by which the hormone contributes to adverse cardiac and vascular remodeling. This review summarizes the work that has been done in evaluating the functional significance of Ang-(1-12) and how this substrate generated from angiotensinogen by a yet to be identified enzyme enhances knowledge about Ang II pathological actions.
Ferrario et al. (Sat,) conducted a review in Cardiac and vascular disease. Angiotensin-(1-12) was evaluated. The dodecapeptide angiotensin-(1-12) generates Ang II directly from chymase in the human heart, providing an alternative noncanonical renin-independent pathway for adverse cardiac remodeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: